isoxsuprine has been researched along with Placenta Previa in 2 studies
Isoxsuprine: A beta-adrenergic agonist that causes direct relaxation of uterine and vascular smooth muscle. Its vasodilating actions are greater on the arteries supplying skeletal muscle than on those supplying skin. It is used in the treatment of peripheral vascular disease and in premature labor.
Placenta Previa: Abnormal placentation in which the PLACENTA implants in the lower segment of the UTERUS (the zone of dilation) and may cover part or all of the opening of the CERVIX. It is often associated with serious antepartum bleeding and PREMATURE LABOR.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matsuda, Y | 1 |
| Ikenoue, T | 1 |
| Hokanishi, H | 1 |
| Tomich, PG | 1 |
2 other studies available for isoxsuprine and Placenta Previa
| Article | Year |
|---|---|
[The perinatal factors associated with the development of neonatal RDS in cases of placenta previa].
Topics: Abruptio Placentae; Asphyxia Neonatorum; Female; Humans; Infant, Newborn; Isoxsuprine; Obstetric Lab | 1986 |
Prolonged use of tocolytic agents in the expectant management of placenta previa.
Topics: Birth Weight; Costs and Cost Analysis; Female; Gestational Age; Humans; Infant, Low Birth Weight; In | 1985 |